These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27178125)

  • 1. Use of selective serotonin reuptake inhibitors (SSRIs) in women delivering liveborn infants and other women of child-bearing age within the U.S. Food and Drug Administration's Mini-Sentinel program.
    Andrade SE; Reichman ME; Mott K; Pitts M; Kieswetter C; Dinatale M; Stone MB; Popovic J; Haffenreffer K; Toh S
    Arch Womens Ment Health; 2016 Dec; 19(6):969-977. PubMed ID: 27178125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy.
    Colvin L; Slack-Smith L; Stanley FJ; Bower C
    Birth Defects Res A Clin Mol Teratol; 2011 Mar; 91(3):142-52. PubMed ID: 21381184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
    Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
    JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary selective serotonin reuptake inhibitors across critical windows of pregnancy establishment: a prospective cohort study of fecundability and pregnancy loss.
    Sjaarda LA; Radoc JG; Flannagan KS; Mumford SL; Kim K; Perkins NJ; Silver RM; Schisterman EF
    Fertil Steril; 2020 Dec; 114(6):1278-1287. PubMed ID: 33066974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries.
    Kieler H; Artama M; Engeland A; Ericsson O; Furu K; Gissler M; Nielsen RB; Nørgaard M; Stephansson O; Valdimarsdottir U; Zoega H; Haglund B
    BMJ; 2012 Jan; 344():d8012. PubMed ID: 22240235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden.
    Zoega H; Kieler H; Nørgaard M; Furu K; Valdimarsdottir U; Brandt L; Haglund B
    PLoS One; 2015; 10(12):e0144474. PubMed ID: 26657647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of antidepressant medications during pregnancy: a multisite study.
    Andrade SE; Raebel MA; Brown J; Lane K; Livingston J; Boudreau D; Rolnick SJ; Roblin D; Smith DH; Willy ME; Staffa JA; Platt R
    Am J Obstet Gynecol; 2008 Feb; 198(2):194.e1-5. PubMed ID: 17905176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations.
    Laine K; Heikkinen T; Ekblad U; Kero P
    Arch Gen Psychiatry; 2003 Jul; 60(7):720-6. PubMed ID: 12860776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population-based study in six European regions.
    Charlton RA; Jordan S; Pierini A; Garne E; Neville AJ; Hansen AV; Gini R; Thayer D; Tingay K; Puccini A; Bos HJ; Nybo Andersen AM; Sinclair M; Dolk H; de Jong-van den Berg LT
    BJOG; 2015 Jun; 122(7):1010-20. PubMed ID: 25352424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of Medication Use During Pregnancy in the Mini-Sentinel Program.
    Andrade SE; Toh S; Houstoun M; Mott K; Pitts M; Kieswetter C; Ceresa C; Haffenreffer K; Reichman ME
    Matern Child Health J; 2016 Apr; 20(4):895-903. PubMed ID: 26645616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy.
    Engelstad HJ; Roghair RD; Calarge CA; Colaizy TT; Stuart S; Haskell SE
    Neonatology; 2014; 105(2):149-54. PubMed ID: 24356332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
    Colvin L; Slack-Smith L; Stanley FJ; Bower C
    CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
    Furu K; Kieler H; Haglund B; Engeland A; Selmer R; Stephansson O; Valdimarsdottir UA; Zoega H; Artama M; Gissler M; Malm H; Nørgaard M
    BMJ; 2015 Apr; 350():h1798. PubMed ID: 25888213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.
    Jordan S; Morris JK; Davies GI; Tucker D; Thayer DS; Luteijn JM; Morgan M; Garne E; Hansen AV; Klungsøyr K; Engeland A; Boyle B; Dolk H
    PLoS One; 2016; 11(12):e0165122. PubMed ID: 27906972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of Chiari I malformation in children of mothers with depression with and without prenatal SSRI exposure.
    Knickmeyer RC; Meltzer-Brody S; Woolson S; Hamer RM; Smith JK; Lury K; Gilmore JH
    Neuropsychopharmacology; 2014 Oct; 39(11):2611-21. PubMed ID: 24837031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
    J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
    Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
    Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI).
    Malm H; Artama M; Brown AS; Gissler M; Gyllenberg D; Hinkka-Yli-Salomäki S; McKeague I; Sourander A
    BMC Psychiatry; 2012 Dec; 12():217. PubMed ID: 23206294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study.
    Pedersen LH; Henriksen TB; Vestergaard M; Olsen J; Bech BH
    BMJ; 2009 Sep; 339():b3569. PubMed ID: 19776103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.